The Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, National Children's Regional Medical Center, Hangzhou, Zhejiang, China.
J Med Virol. 2022 Apr;94(4):1655-1669. doi: 10.1002/jmv.27536. Epub 2021 Dec 30.
To explore the influence of changes in human lifestyle and the living environment caused by nonpharmaceutical interventions in coronavirus disease 2019 (COVID-19) on allergic diseases, the present study enrolled children who came to the Children's Hospital of Zhejiang University for allergen detection between January 2019 and December 2020. By comparing the positive rates and levels of various allergen-specific immunoglobulin E (IgE) before and during the COVID-19 pandemic, the influence of changes in human lifestyle and the living environment caused by prevention and control measures in COVID-19 on allergic diseases was evaluated. In 2019, 41 648 allergic children went to the hospital, but in 2020, due to the impact of the COVID-19 epidemic, the number decreased to 24 714. In 2020, the number of allergy visits was the lowest in February and gradually increased. There were 45 879 children with total IgE > 17.5 IU/ml in 2 years, accounting for 69.13% of the total samples, of which the proportion was 68.52% (28 536/41 648) in 2019 and 70.17% (17 343/24 714) in 2020. A total of 29 906 children were positive for one or more allergens in 2 years. It accounts for 45.06% of the total number of samples, of which the proportion is 41.53% (17 296/41 648) in 2019 and 51.02% (12 610/24 714) in 2020. Except for cashew nuts, the positive number of other allergens in 2020 was less than in 2019, especially after June and July 2020. Except for Artemisia argyi, the positive rates of other allergens in 2020 were significantly higher than those in 2019 (p < 0.05). Moreover, the changing trend of the positive allergen rate in each month in 2020 was different from that in 2019. In 2020, except for Dermatophagoides farinae, Dermatophagoides pteronyssinus, and Crab, specific IgE levels of other allergens were not greater than those in 2019 (p < 0.05). Thus it can be seen, during the COVID-19 pandemic, nonpharmaceutical interventions played a protective role in reducing children's exposure to allergens and alleviating allergic reactions.
为了探讨 2019 年冠状病毒病(COVID-19)期间非药物干预措施对人类生活方式和生活环境改变对过敏性疾病的影响,本研究纳入了 2019 年 1 月至 2020 年 12 月期间在浙江大学儿童医院进行过敏原检测的儿童。通过比较 COVID-19 大流行前后各种过敏原特异性免疫球蛋白 E(IgE)的阳性率和水平,评估 COVID-19 防控措施对过敏性疾病的影响。2019 年,有 41648 名过敏儿童前往医院,但 2020 年由于 COVID-19 疫情的影响,就诊人数减少至 24714 人。2020 年,过敏就诊人数 2 月最低,逐渐增加。两年内共有 45879 名总 IgE>17.5IU/ml 的儿童,占总样本的 69.13%,其中 2019 年占 68.52%(28536/41648),2020 年占 70.17%(17343/24714)。两年内共有 29906 名儿童对一种或多种过敏原呈阳性,占总样本的 45.06%,其中 2019 年占 41.53%(17296/41648),2020 年占 51.02%(12610/24714)。除腰果外,2020 年其他过敏原的阳性数量均少于 2019 年,尤其是 2020 年 6 月和 7 月之后。除艾蒿外,2020 年其他过敏原的阳性率均显著高于 2019 年(p<0.05)。此外,2020 年各月阳性过敏原率的变化趋势与 2019 年不同。2020 年,除粉尘螨、屋尘螨和蟹外,其他过敏原的特异性 IgE 水平均小于 2019 年(p<0.05)。由此可见,在 COVID-19 大流行期间,非药物干预措施在减少儿童接触过敏原和缓解过敏反应方面发挥了保护作用。